Innovation versus financialization in the us pharmaceutical industry
Auteur :
Tulum, Öner / Lazonick, William
Éditeur :
Cambridge University Press
ISBN :
9781009707985
Date de publication :
20 nov. 2025
Poids :
152 g
Format :
Trade paperback (US)
Langue :
Anglais
Pays d'origine :
Grande Bretagne
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'